Frontlight ResearchEarly access
Trial site
Bundang Gu
- 8running trials
- 6closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- IgA nephropathy2 trials
- Stroke2 trials
- Acute lymphoblastic leukaemia1 trial
- Asthma1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Diabetic eye disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Familial hypercholesterolaemia1 trial
- and 5 more
- Phase
- Phase 311 trials
- Status
- Active, not recruiting6 trials
- Completed6 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals14 trials
Running trials
Recruiting
Active, not recruiting
Recruiting
Long-term Follow up Local Registry Study of Kymriah in South Korea
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Sjögren's disease1 recruiting
Closed trials
Completed
Completed
Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026